Author Guidelines

1. Introduction

Journal of Current Hematology & Oncology Research (JCHOR) accepts submissions in English, which is the sole language of publication and editorial processing. Manuscripts must be original, approved by all authors, and must not have been previously published or be under consideration elsewhere. All submissions are processed through an online submission system.

2. Manuscript Preparation: General Formatting

Manuscripts must be prepared in Microsoft Word, using A4 paper size with 2.5 cm margins on all sides. Text must be double-spaced in 12-point Times New Roman font. International System of Units (SI) should be used.

The following formatting rules apply:

• Abbreviations must be defined upon first use in both the abstract and main text.
• Authors should avoid abbreviations in the title.
• Decimal points should be indicated by a comma (e.g., 55,78).
• When mentioning a drug, product, hardware, or software, the product name, manufacturer, city, and country must be provided in parentheses.
• The main document file must be blinded for peer review, with all author and institutional identifiers removed.

Text and tables should be in MS Word format. Figures and images should be submitted in JPEG format with a minimum resolution of 300 DPI.

3. Article Types and Requirements

Identification of the correct article type is the first step in submission, as it dictates the specific formatting and word limits.

3.1. Original Article
Presents substantial novel research, including clinical trials, observational studies, diagnostic accuracy studies, systematic reviews, meta-analyses, and experimental studies.

• Abstract: Structured (Aims, Methods, Results, Conclusion), with a recommended length of 150–500 words.
• Main Text: Structured as Introduction, Methods, Results, Discussion, Conclusion, Acknowledgments, and References, as applicable.
• References: The number of references should be between 10 and 80.
• Tables and Figures: There is no limitation on the number of tables and figures.
• Other: Ethical approval is required for all studies involving human or animal subjects.

3.2. Case Report / Brief Report
Presents rare cases, novel diagnostic or therapeutic challenges, or preliminary findings.

• Abstract: Unstructured, with a recommended length of 100–300 words.
• Main Text: Structured as Introduction, Case Report, and Discussion.
• References: The number of references should be between 5 and 30.
• Tables and Figures: There is no limitation on the number of tables and figures.
• Other: A statement confirming that informed consent was obtained from the patient(s) is required.

3.3. Review Article
Provides comprehensive analyses of specific topics. May be invited, but unsolicited submissions are welcomed.

• Abstract: Unstructured, with a recommended length of 150–500 words.
• Main Text: Structured according to the type and scope of the review.
• References: The number of references should be between 20 and 80.
• Tables and Figures: There is no limitation on the number of tables and figures.
• Other: Does not require ethical approval.

3.4. Letter to the Editor
Offers commentary on articles published in the journal or discusses current developments.

• Abstract: Not required.
• Main Text: Unstructured.
• References: The number of references should be between 1 and 20.
• Tables and Figures: A maximum of one table and one figure may be included.

3.5. Editorial Comment
A brief critical commentary, typically invited by the Editor-in-Chief, on a recently published article.

• Abstract: Not required.
• Main Text: Unstructured.
• References: The number of references should be between 5 and 30.
• Tables and Figures: Tables and figures may be included when appropriate.
• Other: Keywords are included.

4. Clinical Trials and Reporting Guidelines

Registration of clinical trials in a publicly accessible registry (e.g., ClinicalTrials.gov or a WHO ICTRP primary registry) is encouraged. The registry name and number must be provided at the end of the abstract. Authors are advised to consult the EQUATOR network (http://www.equator-network.org/) for appropriate reporting guidelines.

5. Manuscript Submission

The entire submission process is completed online. The submission should be divided into SEPARATE files:

5.1. Cover Letter
Must include the article title, corresponding author's name, article type, and statements regarding:

• Conflict of interest (presence or absence).
• Confirmation that the manuscript is original, not published elsewhere, and not under simultaneous consideration.
• Details of any previous presentations (date, place, format).

5.2. Title Page
A separate file containing:

• Full manuscript title (Recommended Max. 150 characters) and running title (Recommended Max. 50 characters).
• Full names, affiliations, ORCID IDs, and e-mail addresses of all authors.
• Corresponding author's contact information.
• Acknowledgments and funding statements.
• Information on previous presentations, if applicable.

5.3. Main Document
A blinded file containing, in order:

• Abstract and Keywords: Abstract and keywords should be provided according to the requirements of the selected article type. When required, 3–6 keywords from MeSH must be provided.
• Main Text: Structured according to article type.
• References: Numbered consecutively in the order of citation.
• Figure Legends: Listed on a separate page after references.

5.4. Tables
Each table should be submitted as a separate file, numbered consecutively, and cited in the text.

5.5. Figures
Each figure should be uploaded as a separate file in JPEG format (min. 300 DPI). Any identifying information must be blinded.

5.6. Ethics Committee Approval Form
A copy of the ethics committee approval must be provided for all relevant studies, stating the committee name, date, and approval number.

5.7. Copyright Agreement and Acknowledgement of Authorship Form
All authors must meet the ICMJE authorship criteria and sign this form, which is available on JCHOR’s website.

5.8. ICMJE Conflict of Interest Form
The completed form must be submitted with the manuscript.

5.9. Data Availability Statement
Authors are encouraged to share the data supporting their research findings. Datasets, supplementary tables, supplementary figures, questionnaires, and other relevant supporting materials used in the manuscript should be uploaded to the TÜBİTAK ULAKBİM Aperta Open Archive System, where applicable. A persistent identifier (e.g., DOI) or permanent link to the uploaded supplementary materials must be provided in the Data Availability Statement of the manuscript.

6. References

References must follow the AMA-11 style and be numbered consecutively in the order they are cited in the text using superscript Arabic numerals.

Examples:

• Journal Article: Freund KB, Staurenghi G, Jung JJ, et al. Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: Post hoc analysis of HARBOR. Graefes Arch Clin Exp Ophthalmol. 2022;260(8):2437-2447.
• Book Chapter: Bliss CM, Wolfe M. Chapter 34. Common clinical manifestations of gastrointestinal disease. In: Andreoli TE, Cecil RL, eds. Andreoli’s and Carpenter's Cecil Essentials of Medicine. 8th ed. Saunders/Elsevier; 2010:382-400.
• Online Article: Morse SS. Factors affecting the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 June 5]: 1(1). Available from: URL.

When there are six or fewer authors, all should be listed. For seven or more, list the first three followed by "et al."

7. ORCID

Providing an ORCID iD for the corresponding author is mandatory. ORCID iDs for all co-authors are strongly recommended. iDs can be registered at https://orcid.org/register.

8. Publication Process

The editorial and publication process consists of the following stages:

Initial Screening: The submitted manuscript is checked for compliance with journal requirements and basic submission criteria.
Editorial Scope Check: The manuscript is evaluated for suitability within the scope of the journal and relevant scientific field.
Peer Reviewer Assignment: Appropriate reviewers are assigned for scientific evaluation.
Editorial Decision: The Editor makes a decision based on reviewer comments. If necessary, authors are invited to submit a revised version of the manuscript.
Acceptance or Rejection: The manuscript is either accepted for publication or rejected based on the evaluation process.
Final Proofreading: Accepted manuscripts undergo final language and technical checks.
Typesetting: The manuscript is prepared for publication format.
Publication: The final version is published online and/or in the scheduled issue.